Thomas Stankovich

Insider Reports History

Location
San Clemente, CA
Signature
/s/ Thomas Stankovich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Stankovich:

Company Role Class Num Shares Value Price $ Report Date Ownership
ReShape Lifesciences Inc. Chief Financial Officer Common Stock, $0.001 par value per share 22,949 $6,196 $0.2700 25 Oct 2023 Direct
ReShape Lifesciences Inc. Chief Financial Officer Common Stock, $0.001 par value per share 22,777 $5,694 $0.2500 31 May 2024 Direct
ReShape Lifesciences Inc. Chief Financial Officer Common Stock, $0.001 par value per share 0 15 Jun 2021 Direct

Insider Reports Filed by Thomas Stankovich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RSLS ReShape Lifesciences Inc. 30 Nov 2023 4 -$38.78 4 Chief Financial Officer 13 Aug 2024, 16:29
RSLS ReShape Lifesciences Inc. 04 Aug 2023 5 -$386 4 Chief Financial Officer 08 Nov 2023, 16:16
RSLS ReShape Lifesciences Inc. 06 Jul 2023 1 -$156 4 Chief Financial Officer 19 Jul 2023, 16:07
RSLS ReShape Lifesciences Inc. 31 Mar 2023 4 +$26,161 4 Chief Financial Officer 06 Jul 2023, 16:16
RSLS ReShape Lifesciences Inc. 24 Jan 2023 4 -$3,708 4 Chief Financial Officer 07 Mar 2023, 15:11
RSLS ReShape Lifesciences Inc. 17 Nov 2022 4 -$62,938 4 Chief Financial Officer 20 Dec 2022, 15:35
RSLS ReShape Lifesciences Inc. 04 Nov 2022 2 -$2,287 4 Chief Financial Officer 10 Nov 2022, 15:10
RSLS ReShape Lifesciences Inc. 04 Oct 2022 2 -$2,329 4 CFO 06 Oct 2022, 17:29
RSLS ReShape Lifesciences Inc. 06 Sep 2022 1 -$1,883 4 Chief Financial Officer 12 Sep 2022, 16:05
RSLS ReShape Lifesciences Inc. 05 Aug 2022 1 -$2,222 4 Chief Financial Officer 11 Aug 2022, 16:30
RSLS ReShape Lifesciences Inc. 01 Jul 2022 1 -$2,546 4 Chief Financial Officer 06 Jul 2022, 16:08
RSLS ReShape Lifesciences Inc. 01 Jun 2022 1 -$4,299 4 Chief Financial Officer 06 Jun 2022, 16:49
RSLS ReShape Lifesciences Inc. 31 May 2022 8 +$18,422 4 Chief Financial Officer 01 Jun 2022, 14:18
RSLS ReShape Lifesciences Inc. 05 May 2022 1 -$3,487 4 Chief Financial Officer 12 May 2022, 16:05
RSLS ReShape Lifesciences Inc. 01 Apr 2022 1 -$5,693 4 Chief Financial Officer 08 Apr 2022, 16:27
RSLS ReShape Lifesciences Inc. 28 Feb 2022 1 -$3,877 4 CFO 02 Mar 2022, 15:15
RSLS ReShape Lifesciences Inc. 31 Jan 2022 1 -$4,494 4 Chief Financial Officer 02 Feb 2022, 15:22
RSLS ReShape Lifesciences Inc. 04 Jan 2022 1 -$5,644 4 Chief Financial Officer 28 Jan 2022, 15:46
RSLS ReShape Lifesciences Inc. 02 Dec 2021 1 -$7,863 4 Chief Financial Officer 09 Dec 2021, 15:17
RSLS ReShape Lifesciences Inc. 18 Nov 2021 1 +$40,400 4 Chief Financial Officer 18 Nov 2021, 15:32
RSLS ReShape Lifesciences Inc. 02 Nov 2021 1 -$11,621 4 Chief Financial Officer 16 Nov 2021, 15:14
RSLS ReShape Lifesciences Inc. 01 Oct 2021 1 -$10,102 4 Chief Financial Officer 12 Oct 2021, 19:40
RSLS ReShape Lifesciences Inc. 30 Aug 2021 1 +$51,435 4 Chief Financial Officer 31 Aug 2021, 16:31
RSLS ReShape Lifesciences Inc. 20 Aug 2021 1 +$48,285 4 Chief Financial Officer 24 Aug 2021, 08:59
RSLS ReShape Lifesciences Inc. 22 Jul 2021 3 -$139,778 4 Chief Financial Officer 17 Sep 2021, 18:51
RSLS ReShape Lifesciences Inc. 15 Jun 2021 0 $0 3 Chief Financial Officer, Director 24 Jun 2021, 17:29
RSLS ReShape Lifesciences Inc. 15 Jun 2021 1 -$14,137 4 Chief Financial Officer 17 Jun 2021, 16:06